Meningitis is a substantial contributor to mortality in children younger than 5 years of age in low- and middle-income countries.

Children with health care-associated vs nonhealth care-associated RSV were more likely to require escalation of respiratory support.

Timely remdesivir treatment in immunocompromised patients infected with COVID-19 is associated with improved survival outcomes.

Results of a small study suggest similar pathophysiology of cognitive dysfunction and neuropathic pain in patients with long COVID.

Adhering to a healthy prenatal diet may reduce patterns of infant growth outside reference ranges, according to study findings.

Among health care personnel, influenza vaccination has not returned to 2019 levels, and COVID-19 vaccinations have been decreasing.

Work-time, rather than leisure-time or nonworkday, activity behavior seems to be associated with 24-hour ambulatory blood pressure.

Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.

Mpox risk factors among MSM and transgender adults include intimate close contact, especially condomless receptive anal sex.

In utero exposure to COVID-19 infection during pregnancy is not associated with impaired neurodevelopmental outcomes in children through age 24 months.

Remdesivir treatment reduces the risk for 30-day COVID-19-related hospital readmission among all patients discharged alive from initial hospitalization.